{"transactions":[{"id":969828,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2025-12-15T22:22:59.000Z","date":"2025-12-12","kind":"sale","planned":false,"acquired":false,"shares":6500,"price":21.0444,"value":136788.6,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $30.765 to $31.60. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Manchester Explorer, L.P. (\"Explorer\"), (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":63999,"source":{"system":"sec-edgar","filing":"0000919574-25-007394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957425007394/ownership.xml","form_type":"4"}},{"id":969827,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2025-12-15T22:22:59.000Z","date":"2025-12-11","kind":"sale","planned":false,"acquired":false,"shares":13500,"price":31.2798,"value":422277.3,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $31.05 to $31.525. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Manchester Explorer, L.P. (\"Explorer\"), (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":70499,"source":{"system":"sec-edgar","filing":"0000919574-25-007394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957425007394/ownership.xml","form_type":"4"}},{"id":972917,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2025-12-11T20:08:20.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":31.6017,"value":63203.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $29.88 to $33.50. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The reported securities are directly owned by James E. Besser in his personal capacity."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0000919574-25-007331","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957425007331/ownership.xml","form_type":"4/A","original_submission_date":"2025-12-10"}},{"id":972916,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2025-12-11T20:08:20.000Z","date":"2025-12-10","kind":"sale","planned":false,"acquired":false,"shares":8625,"price":30.3918,"value":262129.275,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $30.01 to $30.90. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":863980,"source":{"system":"sec-edgar","filing":"0000919574-25-007331","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957425007331/ownership.xml","form_type":"4/A","original_submission_date":"2025-12-10"}},{"id":972915,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2025-12-11T20:08:20.000Z","date":"2025-12-09","kind":"sale","planned":false,"acquired":false,"shares":8785,"price":30.5838,"value":268678.683,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $30.00 to $31.71. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":872605,"source":{"system":"sec-edgar","filing":"0000919574-25-007331","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957425007331/ownership.xml","form_type":"4/A","original_submission_date":"2025-12-10"}},{"id":972914,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2025-12-11T20:08:20.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":125400,"price":30.75,"value":3856050.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":881390,"source":{"system":"sec-edgar","filing":"0000919574-25-007331","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957425007331/ownership.xml","form_type":"4/A","original_submission_date":"2025-12-10"}},{"id":974767,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2025-12-11T02:21:02.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":31.6017,"value":63203.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $29.88 to $33.50. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The reported securities are directly owned by James E. Besser in his personal capacity."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0000919574-25-007315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957425007315/ownership.xml","form_type":"4"}},{"id":974766,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2025-12-11T02:21:02.000Z","date":"2025-12-10","kind":"sale","planned":false,"acquired":false,"shares":8625,"price":30.3918,"value":262129.275,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $30.01 to $30.90. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":863980,"source":{"system":"sec-edgar","filing":"0000919574-25-007315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957425007315/ownership.xml","form_type":"4"}},{"id":974765,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2025-12-11T02:21:02.000Z","date":"2025-12-09","kind":"sale","planned":false,"acquired":false,"shares":8785,"price":30.5838,"value":268678.683,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $30.00 to $31.71. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":872605,"source":{"system":"sec-edgar","filing":"0000919574-25-007315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957425007315/ownership.xml","form_type":"4"}},{"id":974764,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2025-12-11T02:21:02.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":125400,"price":30.75,"value":3856050.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":881390,"source":{"system":"sec-edgar","filing":"0000919574-25-007315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957425007315/ownership.xml","form_type":"4"}},{"id":1165060,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":true,"officer_title":"Chief Executive Officer","other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":2,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":3,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":5,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":80466,"kind":"organization","name":"JEB Partners, L.P.","position":6,"cik":"0001093241","reported_name":"JEB Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Option to purchase common stock","published_at":"2025-04-28T16:39:32.000Z","date":"2025-04-24","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0.94,"value":117500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted to the Reporting Person in accordance with the Issuer's Fiscal 2026 Two-Part FDA Submission and Product Milestone Bonus Program. The options will vest in two parts: (i) 50% if the Issuer submits a 510k related to MODDi to the FDA on or before October 31, 2025 and (ii) the remaining 50% if the manufacturing line is validated on MODDi with capacity to serve 6,000 patients by March 15, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were granted to the Reporting Person in accordance with the Issuer's Fiscal 2026 Two-Part FDA Submission and Product Milestone Bonus Program. The options will vest in two parts: (i) 50% if the Issuer submits a 510k related to MODDi to the FDA on or before October 31, 2025 and (ii) the remaining 50% if the manufacturing line is validated on MODDi with capacity to serve 6,000 patients by March 15, 2026."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are directly owned by James E. Besser in his personal capacity."}],"balance_after":125000,"derivative":{"exercise_price":0.94,"exercise_date":"2025-04-24","expiration_date":"2035-04-24","underlying":"Common Stock, par value $0.001 per share","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000919574-25-002637","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093241/000091957425002637/ownership.xml","form_type":"4"}},{"id":1193962,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":true,"officer_title":"Chief Executive Officer","other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":2,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":3,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":5,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":80466,"kind":"organization","name":"JEB Partners, L.P.","position":6,"cik":"0001093241","reported_name":"JEB Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2025-03-24T21:34:00.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":78125,"price":1.12,"value":87500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"James E. Besser acquired 78,125 units consisting of two shares of Common Stock, par value $0.001 per share and one warrant to purchase one share of Common Stock, par value $0.001 per share. It is anticipated that the warrants will become exercisable on or about March 25, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"James E. Besser acquired 78,125 units consisting of two shares of Common Stock, par value $0.001 per share and one warrant to purchase one share of Common Stock, par value $0.001 per share. It is anticipated that the warrants will become exercisable on or about March 25, 2025."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The reported securities are directly owned by James E. Besser in his personal capacity."}],"balance_after":78125,"derivative":{"exercise_price":1.12,"exercise_date":"2025-03-25","expiration_date":"2029-03-25","underlying":"Common Stock, par value $0.001 per share","underlying_shares":78125},"source":{"system":"sec-edgar","filing":"0000919574-25-002089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1093241/000091957425002089/ownership.xml","form_type":"4"}},{"id":1193961,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":true,"officer_title":"Chief Executive Officer","other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":2,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":3,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":5,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":80466,"kind":"organization","name":"JEB Partners, L.P.","position":6,"cik":"0001093241","reported_name":"JEB Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2025-03-24T21:34:00.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":260416,"price":1.12,"value":291665.92,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Manchester Explorer, L.P. (\"Explorer\") acquired 260,416 units consisting of two shares of Common Stock, par value $0.001 per share and one warrant to purchase one share of Common Stock, par value $0.001 per share. It is anticipated that the warrants will become exercisable on or about March 25, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Manchester Explorer, L.P. (\"Explorer\") acquired 260,416 units consisting of two shares of Common Stock, par value $0.001 per share and one warrant to purchase one share of Common Stock, par value $0.001 per share. It is anticipated that the warrants will become exercisable on or about March 25, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are owned directly by Explorer and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) and James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":260416,"derivative":{"exercise_price":1.12,"exercise_date":"2025-03-25","expiration_date":"2029-03-25","underlying":"Common Stock, par value $0.001 per share","underlying_shares":260416},"source":{"system":"sec-edgar","filing":"0000919574-25-002089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1093241/000091957425002089/ownership.xml","form_type":"4"}},{"id":1193960,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":true,"officer_title":"Chief Executive Officer","other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":2,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":3,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":5,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":80466,"kind":"organization","name":"JEB Partners, L.P.","position":6,"cik":"0001093241","reported_name":"JEB Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-24T21:34:00.000Z","date":"2025-03-20","kind":"purchase","planned":false,"acquired":true,"shares":156250,"price":1.92,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"James E. Besser acquired 78,125 units consisting of two shares of Common Stock, par value $0.001 per share and one warrant to purchase one share of Common Stock, par value $0.001 per share. It is anticipated that the warrants will become exercisable on or about March 25, 2025."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The reported securities are directly owned by James E. Besser in his personal capacity."}],"balance_after":422000,"source":{"system":"sec-edgar","filing":"0000919574-25-002089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093241/000091957425002089/ownership.xml","form_type":"4"}},{"id":1193959,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":true,"officer_title":"Chief Executive Officer","other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":2,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":3,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":5,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":80466,"kind":"organization","name":"JEB Partners, L.P.","position":6,"cik":"0001093241","reported_name":"JEB Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-24T21:34:00.000Z","date":"2025-03-20","kind":"purchase","planned":false,"acquired":true,"shares":520832,"price":1.92,"value":999997.44,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Manchester Explorer, L.P. (\"Explorer\") acquired 260,416 units consisting of two shares of Common Stock, par value $0.001 per share and one warrant to purchase one share of Common Stock, par value $0.001 per share. It is anticipated that the warrants will become exercisable on or about March 25, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are owned directly by Explorer and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) and James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3805575,"source":{"system":"sec-edgar","filing":"0000919574-25-002089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093241/000091957425002089/ownership.xml","form_type":"4"}},{"id":1343614,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":2,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":3,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":4,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":80466,"kind":"organization","name":"JEB Partners, L.P.","position":5,"cik":"0001093241","reported_name":"JEB Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":6,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-12-04T18:05:34.000Z","date":"2024-12-03","kind":"purchase","planned":false,"acquired":true,"shares":21000,"price":1.6779,"value":35235.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.65 to $1.73. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are directly owned by James E. Besser in his personal capacity."}],"balance_after":265750,"source":{"system":"sec-edgar","filing":"0000919574-24-007009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093241/000091957424007009/ownership.xml","form_type":"4"}},{"id":1348567,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":2,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":3,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":4,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":80466,"kind":"organization","name":"JEB Partners, L.P.","position":5,"cik":"0001093241","reported_name":"JEB Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":6,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-11-29T10:00:09.000Z","date":"2024-11-27","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":1.6895,"value":168950.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) and James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":244750,"source":{"system":"sec-edgar","filing":"0000919574-24-006936","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093241/000091957424006936/ownership.xml","form_type":"4"}},{"id":1353132,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":2,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":3,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":4,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-11-26T00:25:36.000Z","date":"2024-02-16","kind":"purchase","planned":false,"acquired":true,"shares":900000,"price":1.1,"value":990000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The original Form 4 is being amended to update the beneficial ownership information reported therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) and James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) and James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3118077,"source":{"system":"sec-edgar","filing":"0000919574-24-006889","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000091957424006889/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-21"}},{"id":1353156,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":true,"officer_title":"Chief Executive Officer","other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":2,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":3,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":4,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":80466,"kind":"organization","name":"JEB Partners, L.P.","position":5,"cik":"0001093241","reported_name":"JEB Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-11-25T19:46:48.000Z","date":"2024-11-21","kind":"purchase","planned":false,"acquired":true,"shares":166666,"price":1.5,"value":249999.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) and James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3284743,"source":{"system":"sec-edgar","filing":"0000919574-24-006890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093241/000091957424006890/ownership.xml","form_type":"4"}},{"id":1382511,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":14167,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"The reported securities and warrants are directly owned by Morgan C. Frank in his personal capacity."}],"balance_after":0,"derivative":{"exercise_price":25.13,"exercise_date":"2022-08-05","expiration_date":"2027-08-05","underlying":"Common Stock, par value $0.001","underlying_shares":14167},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":36,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382510,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"The reported securities and warrants are directly owned by Morgan C. Frank in his personal capacity."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2022-08-05","expiration_date":"2027-08-05","underlying":"Common Stock, par value $0.001","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":35,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382509,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":22667,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F8","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":25.13,"exercise_date":"2022-11-15","expiration_date":"2027-11-15","underlying":"Common Stock, par value $0.001","underlying_shares":22667},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":34,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382508,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":24000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F8","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2022-11-15","expiration_date":"2027-11-15","underlying":"Common Stock, par value $0.001","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":33,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382507,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":6375,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":25.13,"exercise_date":"2024-01-21","expiration_date":"2024-01-21","underlying":"Common Stock, par value $0.001","underlying_shares":6375},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":32,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382506,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":42498,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":25.13,"exercise_date":"2024-01-21","expiration_date":"2024-01-21","underlying":"Common Stock, par value $0.001","underlying_shares":42498},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":31,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382505,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":6750,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2024-01-21","expiration_date":"2024-01-21","underlying":"Common Stock, par value $0.001","underlying_shares":6750},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382504,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":44998,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2024-01-21","expiration_date":"2024-01-21","underlying":"Common Stock, par value $0.001","underlying_shares":44998},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382503,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Future Advance Convertible Promissory Note","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"exercise","planned":false,"acquired":false,"shares":8625,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2025-01-21","expiration_date":"2025-01-21","underlying":"Common Stock, par value $0.001","underlying_shares":8625},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382502,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Future Advance Convertible Promissory Note","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"exercise","planned":false,"acquired":false,"shares":57498,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2025-01-21","expiration_date":"2025-01-21","underlying":"Common Stock, par value $0.001","underlying_shares":57498},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382501,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":5667,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":25.13,"exercise_date":"2023-12-31","expiration_date":"2028-12-30","underlying":"Common Stock, par value $0.001","underlying_shares":5667},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382500,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":6000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2023-12-31","expiration_date":"2028-12-30","underlying":"Common Stock, par value $0.001","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382499,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Future Advance Convertible Promissory Note","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"exercise","planned":false,"acquired":false,"shares":7667,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2023-12-31","expiration_date":"2024-12-31","underlying":"Common Stock, par value $0.001","underlying_shares":7667},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382498,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":17000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":25.13,"exercise_date":"2023-05-10","expiration_date":"2028-05-10","underlying":"Common Stock, par value $0.001","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382497,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":18000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2023-05-10","expiration_date":"2028-05-10","underlying":"Common Stock, par value $0.001","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382496,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":141667,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":25.13,"exercise_date":"2022-08-05","expiration_date":"2027-08-05","underlying":"Common Stock, par value $0.001","underlying_shares":141667},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382495,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":150000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2022-08-05","expiration_date":"2027-08-05","underlying":"Common Stock, par value $0.001","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382494,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":14167,"price":25.13,"value":356016.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"The reported securities and warrants are directly owned by Morgan C. Frank in his personal capacity."}],"balance_after":52653,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382493,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":15000,"price":15,"value":225000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"The reported securities and warrants are directly owned by Morgan C. Frank in his personal capacity."}],"balance_after":38486,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382492,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":22667,"price":25.13,"value":569621.71,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":83999,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382491,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":24000,"price":15,"value":360000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":61332,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382490,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"purchase","planned":false,"acquired":true,"shares":181818,"price":8.25,"value":1499998.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"On October 16, 2024, Explorer entered into a securities purchase agreement (the \"Purchase Agreement\") with the Issuer, pursuant to which Explorer acquired 181,818 shares of the Issuer's Common Stock from the Issuer in a private placement at a price of $8.25 per share of Common Stock (the \"Private Placement\"), in each case, after adjustment to reflect the Reverse Stock Split. The Private Placement closed on October 18, 2024. The foregoing descriptions of the Purchase Agreement and the Private Placement do not purport to be complete and is subject to and qualified in its entirety by reference to the 8-K, which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F11","text":"On October 16, 2024, Explorer entered into a securities purchase agreement (the \"Purchase Agreement\") with the Issuer, pursuant to which Explorer acquired 181,818 shares of the Issuer's Common Stock from the Issuer in a private placement at a price of $8.25 per share of Common Stock (the \"Private Placement\"), in each case, after adjustment to reflect the Reverse Stock Split. The Private Placement closed on October 18, 2024. The foregoing descriptions of the Purchase Agreement and the Private Placement do not purport to be complete and is subject to and qualified in its entirety by reference to the 8-K, which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"On October 16, 2024, Explorer entered into a securities purchase agreement (the \"Purchase Agreement\") with the Issuer, pursuant to which Explorer acquired 181,818 shares of the Issuer's Common Stock from the Issuer in a private placement at a price of $8.25 per share of Common Stock (the \"Private Placement\"), in each case, after adjustment to reflect the Reverse Stock Split. The Private Placement closed on October 18, 2024. The foregoing descriptions of the Purchase Agreement and the Private Placement do not purport to be complete and is subject to and qualified in its entirety by reference to the 8-K, which is incorporated herein by reference."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F11","text":"On October 16, 2024, Explorer entered into a securities purchase agreement (the \"Purchase Agreement\") with the Issuer, pursuant to which Explorer acquired 181,818 shares of the Issuer's Common Stock from the Issuer in a private placement at a price of $8.25 per share of Common Stock (the \"Private Placement\"), in each case, after adjustment to reflect the Reverse Stock Split. The Private Placement closed on October 18, 2024. The foregoing descriptions of the Purchase Agreement and the Private Placement do not purport to be complete and is subject to and qualified in its entirety by reference to the 8-K, which is incorporated herein by reference."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1006790,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382489,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":6375,"price":25.13,"value":160203.75,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":824971,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382488,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":42498,"price":25.13,"value":1067974.74,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":818596,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382487,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":6750,"price":15,"value":101250.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":776098,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382486,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":44998,"price":15,"value":674970.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":769348,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382485,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"exercise","planned":false,"acquired":true,"shares":8625,"price":15,"value":129375.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":724350,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382484,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"exercise","planned":false,"acquired":true,"shares":57498,"price":15,"value":862470.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":715725,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382483,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":5667,"price":25.13,"value":142411.71,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":658227,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382482,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":6000,"price":15,"value":90000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":652560,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382481,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"exercise","planned":false,"acquired":true,"shares":7667,"price":15,"value":115005.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Pursuant to the terms of the Exchange, each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":646560,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382480,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":17000,"price":25.13,"value":427210.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":638893,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382479,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":18000,"price":15,"value":270000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":621893,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382478,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":141667,"price":25.13,"value":3560091.71,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Exchange, the $25.13 Warrants were each exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":603893,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382477,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-10-23T17:03:42.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":150000,"price":15,"value":2250000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 18, 2024, effective upon the implementation of the Reverse Stock Split (as defined below), the Company issued an aggregate of 3,989,456 shares of Common Stock in exchange for all outstanding (A) Future Advance Convertible Promissory Notes (\"Notes\") and (B) Common Stock Purchase Warrants issued by the Company in private placements in August 2022, November 2022, May 2023, December 2023, January 2024 and June 2024 (collectively, the \"Warrants\") ((A) and (B), together, the \"Exchange\"). Pursuant to the Exchange, after adjustment to reflect the Reverse Stock Split, (i) each outstanding Note was fully accelerated to maturity (with 15% interest paid on the outstanding principal) and then converted (per the terms of the Note) into shares of Common Stock at $15.00 per share, (ii) each Warrant with an exercise price of $15.00 per share (i.e., $0.04 prior to the Reverse Stock Split) was exchanged for 0.0024 shares of"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd from footnote 1) Common Stock per share subject to such Warrant (the \"$15.00 Warrants\"), and (iii) each Warrant with an exercise price of $25.13 per share (i.e., $0.067 prior to the Reverse Stock Split) was exchanged for approximately 0.0023 shares of Common Stock per share subject to such Warrant (the \"$25.13 Warrants\"). Simultaneous with the Exchange, each Warrant was exchanged pursuant to the mechanics reported by the Reporting Persons on the other Form 4 filed on October 22, 2024 by the Reporting Persons, which is incorporated herein by reference. The foregoing transactions, including the Exchange, were approved by the Board of Directors of the Issuer. The foregoing description of the Exchange does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 18, 2024 (the \"8-K\"), which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Exchange, the $15.00 Warrants were each exchanged for approximately 0.0024 shares of Common Stock per share subject to such Warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference. As a result of the foregoing, the number of reported securities herein is on a post-Reverse Stock Split basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":462226,"source":{"system":"sec-edgar","filing":"0000919574-24-005981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005981/ownership.xml","form_type":"4"}},{"id":1382476,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:00:04.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":5667,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F17","text":"Based on the formula contained in the Common Stock Purchase Warrant, the reporting persons may be entitled to receive up to 5,667 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"The warrant may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F17","text":"Based on the formula contained in the Common Stock Purchase Warrant, the reporting persons may be entitled to receive up to 5,667 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."}],"balance_after":5667,"derivative":{"exercise_price":15,"exercise_date":"2023-12-31","expiration_date":"2028-12-30","underlying":"Common Stock, par value $0.001","underlying_shares":5667},"source":{"system":"sec-edgar","filing":"0000919574-24-005980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005980/ownership.xml","form_type":"4"}},{"id":1382475,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:00:04.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":6667,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F17","text":"Based on the formula contained in the Common Stock Purchase Warrant, the reporting persons may be entitled to receive up to 5,667 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"The warrant may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F17","text":"Based on the formula contained in the Common Stock Purchase Warrant, the reporting persons may be entitled to receive up to 5,667 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2023-12-31","expiration_date":"2028-12-30","underlying":"Common Stock, par value $0.001","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0000919574-24-005980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005980/ownership.xml","form_type":"4"}},{"id":1382474,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:00:04.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":6000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F17","text":"Based on the formula contained in the Common Stock Purchase Warrant, the reporting persons may be entitled to receive up to 5,667 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"The warrant may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F17","text":"Based on the formula contained in the Common Stock Purchase Warrant, the reporting persons may be entitled to receive up to 5,667 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."}],"balance_after":6000,"derivative":{"exercise_price":25.13,"exercise_date":"2023-12-31","expiration_date":"2028-12-30","underlying":"Common Stock, par value $0.001","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000919574-24-005980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005980/ownership.xml","form_type":"4"}},{"id":1382473,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:00:04.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":6667,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F17","text":"Based on the formula contained in the Common Stock Purchase Warrant, the reporting persons may be entitled to receive up to 5,667 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"The warrant may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F17","text":"Based on the formula contained in the Common Stock Purchase Warrant, the reporting persons may be entitled to receive up to 5,667 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."}],"balance_after":0,"derivative":{"exercise_price":25.13,"exercise_date":"2023-12-31","expiration_date":"2028-12-30","underlying":"Common Stock, par value $0.001","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0000919574-24-005980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005980/ownership.xml","form_type":"4"}},{"id":1382472,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:00:04.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":6375,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F11","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The amount of Common Stock listed herein is based on an aggregate principal amount of $112,494.38 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F11","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The amount of Common Stock listed herein is based on an aggregate principal amount of $112,494.38 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents."}],"balance_after":6375,"derivative":{"exercise_price":25.13,"underlying":"Common Stock, par value $0.001","underlying_shares":6375},"source":{"system":"sec-edgar","filing":"0000919574-24-005980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005980/ownership.xml","form_type":"4"}},{"id":1382471,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:00:04.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":7500,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F11","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The amount of Common Stock listed herein is based on an aggregate principal amount of $112,494.38 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F11","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The amount of Common Stock listed herein is based on an aggregate principal amount of $112,494.38 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents."}],"balance_after":0,"derivative":{"exercise_price":25.13,"underlying":"Common Stock, par value $0.001","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000919574-24-005980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005980/ownership.xml","form_type":"4"}},{"id":1382470,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:00:04.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":6750,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F11","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The amount of Common Stock listed herein is based on an aggregate principal amount of $112,494.38 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F11","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The amount of Common Stock listed herein is based on an aggregate principal amount of $112,494.38 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents."}],"balance_after":6750,"derivative":{"exercise_price":15,"underlying":"Common Stock, par value $0.001","underlying_shares":6750},"source":{"system":"sec-edgar","filing":"0000919574-24-005980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005980/ownership.xml","form_type":"4"}},{"id":1382469,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:00:04.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":7500,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F11","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The amount of Common Stock listed herein is based on an aggregate principal amount of $112,494.38 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F11","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The amount of Common Stock listed herein is based on an aggregate principal amount of $112,494.38 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents."}],"balance_after":0,"derivative":{"exercise_price":15,"underlying":"Common Stock, par value $0.001","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000919574-24-005980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005980/ownership.xml","form_type":"4"}},{"id":1382468,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:00:04.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":42498,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F9","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.000. The amount of Common Stock listed herein is based on an aggregate principal amount of $749,962.50 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F9","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.000. The amount of Common Stock listed herein is based on an aggregate principal amount of $749,962.50 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents."}],"balance_after":42498,"derivative":{"exercise_price":25.13,"underlying":"Common Stock, par value $0.001","underlying_shares":42498},"source":{"system":"sec-edgar","filing":"0000919574-24-005980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005980/ownership.xml","form_type":"4"}},{"id":1382467,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:00:04.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":49998,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F9","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.000. The amount of Common Stock listed herein is based on an aggregate principal amount of $749,962.50 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F9","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.000. The amount of Common Stock listed herein is based on an aggregate principal amount of $749,962.50 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents."}],"balance_after":0,"derivative":{"exercise_price":25.13,"underlying":"Common Stock, par value $0.001","underlying_shares":49998},"source":{"system":"sec-edgar","filing":"0000919574-24-005980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005980/ownership.xml","form_type":"4"}},{"id":1382466,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:00:04.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":44998,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F9","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.000. The amount of Common Stock listed herein is based on an aggregate principal amount of $749,962.50 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F9","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.000. The amount of Common Stock listed herein is based on an aggregate principal amount of $749,962.50 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents."}],"balance_after":44998,"derivative":{"exercise_price":15,"underlying":"Common Stock, par value $0.001","underlying_shares":44998},"source":{"system":"sec-edgar","filing":"0000919574-24-005980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005980/ownership.xml","form_type":"4"}},{"id":1382465,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T17:00:04.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":49998,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F9","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.000. The amount of Common Stock listed herein is based on an aggregate principal amount of $749,962.50 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Explorer two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.00. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F9","text":"Explorer expects to be entitled to a number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $15.000. The amount of Common Stock listed herein is based on an aggregate principal amount of $749,962.50 (calculated pre-Reverse Stock Split), with fractional shares rounded down."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents."}],"balance_after":0,"derivative":{"exercise_price":15,"underlying":"Common Stock, par value $0.001","underlying_shares":49998},"source":{"system":"sec-edgar","filing":"0000919574-24-005980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005980/ownership.xml","form_type":"4"}},{"id":1382464,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":17000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F8","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2, which is incorporated by reference."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2, which is incorporated by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2, which is incorporated by reference."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":17000,"derivative":{"exercise_price":25.13,"exercise_date":"2023-05-10","expiration_date":"2028-05-10","underlying":"Common Stock, par value $0.001","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1382463,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F8","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2, which is incorporated by reference."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2, which is incorporated by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2, which is incorporated by reference."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":25.13,"exercise_date":"2023-05-10","expiration_date":"2028-05-10","underlying":"Common Stock, par value $0.001","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1382462,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":18000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F8","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2, which is incorporated by reference."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2, which is incorporated by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2, which is incorporated by reference."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":18000,"derivative":{"exercise_price":15,"exercise_date":"2023-05-10","expiration_date":"2028-05-10","underlying":"Common Stock, par value $0.001","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1382461,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F8","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2, which is incorporated by reference."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2, which is incorporated by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2, which is incorporated by reference."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2023-05-10","expiration_date":"2028-05-10","underlying":"Common Stock, par value $0.001","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1382460,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":22667,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F6","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.4 of the Issuer's S-1/A filed on December 22, 2022, which is incorporated by reference."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.4 of the Issuer's S-1/A filed on December 22, 2022, which is incorporated by reference."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":22667,"derivative":{"exercise_price":25.13,"exercise_date":"2022-11-15","expiration_date":"2027-11-15","underlying":"Common Stock, par value $0.001","underlying_shares":22667},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1382459,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":26667,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F6","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.4 of the Issuer's S-1/A filed on December 22, 2022, which is incorporated by reference."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.4 of the Issuer's S-1/A filed on December 22, 2022, which is incorporated by reference."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":25.13,"exercise_date":"2022-11-15","expiration_date":"2027-11-15","underlying":"Common Stock, par value $0.001","underlying_shares":26667},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1382458,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":24000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F6","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.4 of the Issuer's S-1/A filed on December 22, 2022, which is incorporated by reference."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.4 of the Issuer's S-1/A filed on December 22, 2022, which is incorporated by reference."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":24000,"derivative":{"exercise_price":15,"exercise_date":"2022-11-15","expiration_date":"2027-11-15","underlying":"Common Stock, par value $0.001","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1382457,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":26667,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F6","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.4 of the Issuer's S-1/A filed on December 22, 2022, which is incorporated by reference."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.4 of the Issuer's S-1/A filed on December 22, 2022, which is incorporated by reference."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2022-11-15","expiration_date":"2027-11-15","underlying":"Common Stock, par value $0.001","underlying_shares":26667},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1382456,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":14167,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The reported securities and warrants are directly owned by Morgan C. Frank in his personal capacity."}],"balance_after":14167,"derivative":{"exercise_price":25.13,"exercise_date":"2022-08-05","expiration_date":"2027-08-05","underlying":"Common Stock, par value $0.001","underlying_shares":14167},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1382455,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":16667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The reported securities and warrants are directly owned by Morgan C. Frank in his personal capacity."}],"balance_after":0,"derivative":{"exercise_price":25.13,"exercise_date":"2022-08-05","expiration_date":"2027-08-05","underlying":"Common Stock, par value $0.001","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1382454,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The reported securities and warrants are directly owned by Morgan C. Frank in his personal capacity."}],"balance_after":15000,"derivative":{"exercise_price":15,"exercise_date":"2022-08-05","expiration_date":"2027-08-05","underlying":"Common Stock, par value $0.001","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1382453,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":16667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The reported securities and warrants are directly owned by Morgan C. Frank in his personal capacity."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2022-08-05","expiration_date":"2027-08-05","underlying":"Common Stock, par value $0.001","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1382452,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":141667,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":141667,"derivative":{"exercise_price":25.13,"exercise_date":"2022-08-05","expiration_date":"2027-08-05","underlying":"Common Stock, par value $0.001","underlying_shares":141667},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1382451,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":166667,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":25.13,"exercise_date":"2022-08-05","expiration_date":"2027-08-05","underlying":"Common Stock, par value $0.001","underlying_shares":166667},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1382450,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":150000,"derivative":{"exercise_price":15,"exercise_date":"2022-08-05","expiration_date":"2027-08-05","underlying":"Common Stock, par value $0.001","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1382449,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":1,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":2,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":3,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":5,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-10-23T16:56:26.000Z","date":"2024-10-18","kind":"other","planned":false,"acquired":false,"shares":166667,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms."},{"field":"shares","element":"transactionShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the \"Certificate of Amendment\"), to implement a 1-for-375 reverse stock split (the \"Reverse Stock Split\") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 (\"Exhibit 4.2\"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2022-08-05","expiration_date":"2027-08-05","underlying":"Common Stock, par value $0.001","underlying_shares":166667},"source":{"system":"sec-edgar","filing":"0000919574-24-005979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424005979/ownership.xml","form_type":"4"}},{"id":1519348,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Future Advance Convertible Promissory Note","published_at":"2024-05-14T00:49:53.000Z","date":"2024-05-09","kind":"exercise","planned":false,"acquired":false,"price":0.04,"reported_value":345000,"ownership":{"direct":false,"nature":"See footnote (3)."},"footnotes":[{"field":"reported_value","element":"transactionTotalValue","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on May 9, 2023, all principal and accrued and unpaid interest due as of the maturity date, May 9, 2024, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on May 9, 2023, all principal and accrued and unpaid interest due as of the maturity date, May 9, 2024, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on May 9, 2023, all principal and accrued and unpaid interest due as of the maturity date, May 9, 2024, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester PR, the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":0.04,"exercise_date":"2023-05-10","underlying":"Common Stock, par value $0.001","underlying_shares":8625000},"source":{"system":"sec-edgar","filing":"0000919574-24-002866","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424002866/ownership.xml","form_type":"4"}},{"id":1519347,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":4,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":5,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2024-05-14T00:49:53.000Z","date":"2024-05-09","kind":"exercise","planned":false,"acquired":true,"shares":8625000,"price":0.04,"value":345000.0,"ownership":{"direct":false,"nature":"See footnote (3)."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on May 9, 2023, all principal and accrued and unpaid interest due as of the maturity date, May 9, 2024, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester PR, the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":117085646,"source":{"system":"sec-edgar","filing":"0000919574-24-002866","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424002866/ownership.xml","form_type":"4"}},{"id":1630619,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":2,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":3,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":4,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":80466,"kind":"organization","name":"JEB Partners, L.P.","position":5,"cik":"0001093241","reported_name":"JEB Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-02-21T16:50:05.000Z","date":"2024-02-16","kind":"purchase","planned":false,"acquired":true,"shares":900000,"price":1.1,"value":990000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reported securities are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) and James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) and James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3118227,"source":{"system":"sec-edgar","filing":"0000919574-24-001612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093241/000091957424001612/ownership.xml","form_type":"4"}},{"id":1680184,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-01-12T23:57:05.000Z","date":"2023-12-30","kind":"other","planned":false,"acquired":true,"shares":2500000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F24","text":"The warrant may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F23","text":"The exercise of the reported warrants are subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F25","text":"Based on the formula contained in the Common Stock Purchase Warrant, the reporting persons may be entitled to receive up to 2,500,000 shares of Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F25","text":"Based on the formula contained in the Common Stock Purchase Warrant, the reporting persons may be entitled to receive up to 2,500,000 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester PR, the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2500000,"derivative":{"exercise_price":0.04,"expiration_date":"2028-12-30","underlying":"Common Stock, par value $0.001","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0000919574-24-000368","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424000368/ownership.xml","form_type":"4/A","original_submission_date":"2024-01-03"}},{"id":1680183,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-01-12T23:57:05.000Z","date":"2023-12-30","kind":"other","planned":false,"acquired":true,"shares":2500000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F24","text":"The warrant may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F23","text":"The exercise of the reported warrants are subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F25","text":"Based on the formula contained in the Common Stock Purchase Warrant, the reporting persons may be entitled to receive up to 2,500,000 shares of Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F25","text":"Based on the formula contained in the Common Stock Purchase Warrant, the reporting persons may be entitled to receive up to 2,500,000 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester PR, the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2500000,"derivative":{"exercise_price":0.067,"exercise_date":"2023-12-31","expiration_date":"2028-12-30","underlying":"Common Stock, par value $0.001","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0000919574-24-000368","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424000368/ownership.xml","form_type":"4/A","original_submission_date":"2024-01-03"}},{"id":1680182,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Future Advance Convertible Promissory Note","published_at":"2024-01-12T23:57:05.000Z","date":"2023-12-30","kind":"other","planned":false,"acquired":true,"reported_value":2875000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"reported_value","element":"transactionTotalValue","label":"F20","text":"The Reporting Persons are entitled to a number of shares of Common Stock by dividing (x) the sum of (A) the portion of the principal to be converted, redeemed or otherwise with respect to which this determination is being made and (B) accrued and unpaid interest with respect to such principal, and (y) $0.04. The foregoing description of the note does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the notes related, which is substantially similar to the Future Advance Convertible Promissory Note included as Exhibit 4.1+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"price","element":"transactionPricePerShare","label":"F20","text":"The Reporting Persons are entitled to a number of shares of Common Stock by dividing (x) the sum of (A) the portion of the principal to be converted, redeemed or otherwise with respect to which this determination is being made and (B) accrued and unpaid interest with respect to such principal, and (y) $0.04. The foregoing description of the note does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the notes related, which is substantially similar to the Future Advance Convertible Promissory Note included as Exhibit 4.1+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F21","text":"The exercise of the Future Advance Convertible Promissory Note is subject to limitations and conditions on exercise, including the limitation that such notes are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents. The foregoing description of the note does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the notes related, which is substantially similar to the Future Advance Convertible Promissory Note included as Exhibit 4.1+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F22","text":"After all principal, accrued interest and other amounts at any time owed on the note have been paid in full, the note shall automatically be deemed canceled, shall be surrendered to the Issuer for cancellation and shall not be reissued. The foregoing description of the note does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the notes related, which is substantially similar to the Future Advance Convertible Promissory Note included as Exhibit 4.1+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F20","text":"The Reporting Persons are entitled to a number of shares of Common Stock by dividing (x) the sum of (A) the portion of the principal to be converted, redeemed or otherwise with respect to which this determination is being made and (B) accrued and unpaid interest with respect to such principal, and (y) $0.04. The foregoing description of the note does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the notes related, which is substantially similar to the Future Advance Convertible Promissory Note included as Exhibit 4.1+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F20","text":"The Reporting Persons are entitled to a number of shares of Common Stock by dividing (x) the sum of (A) the portion of the principal to be converted, redeemed or otherwise with respect to which this determination is being made and (B) accrued and unpaid interest with respect to such principal, and (y) $0.04. The foregoing description of the note does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the notes related, which is substantially similar to the Future Advance Convertible Promissory Note included as Exhibit 4.1+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester PR, the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2875000,"derivative":{"exercise_price":0.04,"exercise_date":"2023-12-31","underlying":"Common Stock, par value $0.001","underlying_shares":2875000},"source":{"system":"sec-edgar","filing":"0000919574-24-000368","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424000368/ownership.xml","form_type":"4/A","original_submission_date":"2024-01-03"}},{"id":1693509,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-01-03T23:31:13.000Z","date":"2023-12-30","kind":"other","planned":false,"acquired":true,"shares":2500000,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F25","text":"The warrant may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F24","text":"The exercise of the reported warrants are subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F26","text":"Based on the formula contained in the Common Stock Purchase Warrant, the reporting persons may be entitled to receive up to 2,500,000 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester PR, the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2500000,"derivative":{"exercise_price":0.04,"expiration_date":"2028-12-30","underlying":"Common Stock, par value $0.001","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0000919574-24-000048","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424000048/ownership.xml","form_type":"4"}},{"id":1693508,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2024-01-03T23:31:13.000Z","date":"2023-12-30","kind":"other","planned":false,"acquired":true,"shares":2500000,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F25","text":"The warrant may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F24","text":"The exercise of the reported warrants are subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant, including the limitation that such warrants are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the warrants related, which is substantially similar to the Common Stock Purchase Warrant included as Exhibit 4.2+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F26","text":"Based on the formula contained in the Common Stock Purchase Warrant, the reporting persons may be entitled to receive up to 2,500,000 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester PR, the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2500000,"derivative":{"exercise_price":0.067,"exercise_date":"2023-12-31","expiration_date":"2028-12-30","underlying":"Common Stock, par value $0.001","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0000919574-24-000048","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424000048/ownership.xml","form_type":"4"}},{"id":1693507,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Future Advance Convertible Promissory Note","published_at":"2024-01-03T23:31:13.000Z","date":"2023-12-30","kind":"other","planned":false,"acquired":true,"reported_value":100000,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"reported_value","element":"transactionTotalValue","label":"F21","text":"The Reporting Persons are entitled to a number of shares of Common Stock by dividing (x) the sum of (A) the portion of the principal to be converted, redeemed or otherwise with respect to which this determination is being made and (B) accrued and unpaid interest with respect to such principal, and (y) $0.04. The foregoing description of the note does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the notes related, which is substantially similar to the Future Advance Convertible Promissory Note included as Exhibit 4.1+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"price","element":"transactionPricePerShare","label":"F21","text":"The Reporting Persons are entitled to a number of shares of Common Stock by dividing (x) the sum of (A) the portion of the principal to be converted, redeemed or otherwise with respect to which this determination is being made and (B) accrued and unpaid interest with respect to such principal, and (y) $0.04. The foregoing description of the note does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the notes related, which is substantially similar to the Future Advance Convertible Promissory Note included as Exhibit 4.1+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F22","text":"The exercise of the Future Advance Convertible Promissory Note is subject to limitations and conditions on exercise, including the limitation that such notes are not currently exercisable into shares until such time as the Issuer's authorized and unissued shares are at a number sufficient to permit the exercise of all warrants and the conversion or exercise of all other share equivalents. The foregoing description of the note does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the notes related, which is substantially similar to the Future Advance Convertible Promissory Note included as Exhibit 4.1+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F23","text":"After all principal, accrued interest and other amounts at any time owed on the note have been paid in full, the note shall automatically be deemed canceled, shall be surrendered to the Issuer for cancellation and shall not be reissued. The foregoing description of the note does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the notes related, which is substantially similar to the Future Advance Convertible Promissory Note included as Exhibit 4.1+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F21","text":"The Reporting Persons are entitled to a number of shares of Common Stock by dividing (x) the sum of (A) the portion of the principal to be converted, redeemed or otherwise with respect to which this determination is being made and (B) accrued and unpaid interest with respect to such principal, and (y) $0.04. The foregoing description of the note does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the notes related, which is substantially similar to the Future Advance Convertible Promissory Note included as Exhibit 4.1+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F21","text":"The Reporting Persons are entitled to a number of shares of Common Stock by dividing (x) the sum of (A) the portion of the principal to be converted, redeemed or otherwise with respect to which this determination is being made and (B) accrued and unpaid interest with respect to such principal, and (y) $0.04. The foregoing description of the note does not purport to be complete and is subject to and qualified in its entirety by the full agreement to which the notes related, which is substantially similar to the Future Advance Convertible Promissory Note included as Exhibit 4.1+ of the Issuer's S-1/A filed on September 29, 2023, which is incorporated by reference."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester PR, the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":100000,"derivative":{"exercise_price":0.04,"exercise_date":"2023-12-31","underlying":"Common Stock, par value $0.001"},"source":{"system":"sec-edgar","filing":"0000919574-24-000048","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957424000048/ownership.xml","form_type":"4"}},{"id":1733115,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Future Advance Convertible Promissory Note","published_at":"2023-11-21T20:50:50.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":false,"price":0.04,"reported_value":460000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"reported_value","element":"transactionTotalValue","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on November 15, 2022, all principal and accrued and unpaid interest due as of the maturity date, November 15, 2023, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on November 15, 2022, all principal and accrued and unpaid interest due as of the maturity date, November 15, 2023, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on November 15, 2022, all principal and accrued and unpaid interest due as of the maturity date, November 15, 2023, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of JEB Partners, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose"}],"balance_after":0,"derivative":{"exercise_price":0.04,"exercise_date":"2022-11-15","underlying":"Common Stock, par value $0.001","underlying_shares":11500000},"source":{"system":"sec-edgar","filing":"0000919574-23-006492","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957423006492/ownership.xml","form_type":"4"}},{"id":1733114,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2023-11-21T20:50:50.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":true,"shares":11500000,"price":0.04,"value":460000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on November 15, 2022, all principal and accrued and unpaid interest due as of the maturity date, November 15, 2023, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities and warrants are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of JEB Partners, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose"}],"balance_after":14000000,"source":{"system":"sec-edgar","filing":"0000919574-23-006492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957423006492/ownership.xml","form_type":"4"}},{"id":1758452,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":2,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":3,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":80466,"kind":"organization","name":"JEB Partners, L.P.","position":4,"cik":"0001093241","reported_name":"JEB Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-10-18T10:29:29.000Z","date":"2023-10-16","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.0987,"value":21974.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are directly owned by James E. Besser in his personal capacity."}],"balance_after":144750,"source":{"system":"sec-edgar","filing":"0000919574-23-005719","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093241/000091957423005719/ownership.xml","form_type":"4"}},{"id":1758451,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":2,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":3,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":80466,"kind":"organization","name":"JEB Partners, L.P.","position":4,"cik":"0001093241","reported_name":"JEB Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-10-18T10:29:29.000Z","date":"2023-10-16","kind":"purchase","planned":false,"acquired":true,"shares":13000,"price":1.0422,"value":13548.6,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by JEB Partners, L.P. (\"JEB Partners\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC (\"Manchester Management\"), the general partner of JEB Partners, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":330473,"source":{"system":"sec-edgar","filing":"0000919574-23-005719","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093241/000091957423005719/ownership.xml","form_type":"4"}},{"id":1812251,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Future Advance Convertible Promissory Note","published_at":"2023-08-09T23:39:13.000Z","date":"2023-08-07","kind":"exercise","planned":false,"acquired":false,"price":0.04,"reported_value":417712,"ownership":{"direct":true},"footnotes":[{"field":"reported_value","element":"transactionTotalValue","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on August 5, 2022, all principal and accrued and unpaid interest due as of the maturity date, August 5, 2023, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on August 5, 2022, all principal and accrued and unpaid interest due as of the maturity date, August 5, 2023, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on August 5, 2022, all principal and accrued and unpaid interest due as of the maturity date, August 5, 2023, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reported securities and warrants are directly owned by Morgan C. Frank in his personal capacity."}],"balance_after":0,"derivative":{"exercise_price":0.04,"exercise_date":"2022-08-05","underlying":"Common Stock, par value $0.001","underlying_shares":10442806},"source":{"system":"sec-edgar","filing":"0000919574-23-004387","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957423004387/ownership.xml","form_type":"4"}},{"id":1812250,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Future Advance Convertible Promissory Note","published_at":"2023-08-09T23:39:13.000Z","date":"2023-08-07","kind":"exercise","planned":false,"acquired":false,"price":0.04,"reported_value":2875000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"reported_value","element":"transactionTotalValue","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on August 5, 2022, all principal and accrued and unpaid interest due as of the maturity date, August 5, 2023, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on August 5, 2022, all principal and accrued and unpaid interest due as of the maturity date, August 5, 2023, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on August 5, 2022, all principal and accrued and unpaid interest due as of the maturity date, August 5, 2023, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":0.04,"exercise_date":"2022-08-05","underlying":"Common Stock, par value $0.001","underlying_shares":71875000},"source":{"system":"sec-edgar","filing":"0000919574-23-004387","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957423004387/ownership.xml","form_type":"4"}},{"id":1812249,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2023-08-09T23:39:13.000Z","date":"2023-08-07","kind":"exercise","planned":false,"acquired":true,"shares":10442806,"price":0.04,"value":417712.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on August 5, 2022, all principal and accrued and unpaid interest due as of the maturity date, August 5, 2023, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reported securities and warrants are directly owned by Morgan C. Frank in his personal capacity."}],"balance_after":11942806,"source":{"system":"sec-edgar","filing":"0000919574-23-004387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957423004387/ownership.xml","form_type":"4"}},{"id":1812248,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock, par value $0.001","published_at":"2023-08-09T23:39:13.000Z","date":"2023-08-07","kind":"exercise","planned":false,"acquired":true,"shares":71875000,"price":0.04,"value":2875000.0,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of the Future Advance Convertible Promissory Note issued on August 5, 2022, all principal and accrued and unpaid interest due as of the maturity date, August 5, 2023, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":108460646,"source":{"system":"sec-edgar","filing":"0000919574-23-004387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957423004387/ownership.xml","form_type":"4"}},{"id":1822304,"issuer":{"id":7321,"kind":"organization","name":"SANUWAVE Health, Inc."},"owners":[{"id":71588,"kind":"organization","name":"MANCHESTER MANAGEMENT CO LLC","position":1,"cik":"0001169253","reported_name":"MANCHESTER MANAGEMENT CO LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71589,"kind":"organization","name":"Manchester Explorer, L.P.","position":2,"cik":"0001411524","reported_name":"Manchester Explorer, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":71591,"kind":"organization","name":"MANCHESTER MANAGEMENT PR, LLC","position":3,"cik":"0001735534","reported_name":"MANCHESTER MANAGEMENT PR, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}},{"id":32790,"kind":"person","name":"FRANK MORGAN C.","position":4,"cik":"0001593072","reported_name":"FRANK MORGAN C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":71590,"kind":"person","name":"BESSER JAMES E","position":5,"cik":"0001512127","reported_name":"BESSER JAMES E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock Purchase Warrant","published_at":"2023-07-27T13:11:37.000Z","date":"2023-07-24","kind":"other","planned":false,"acquired":true,"shares":1875000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F22","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Manchester Explorer, L.P. two Common Stock Purchase Warrants, one with an exercise price of $0.04 per share and one with an exercise price of $0.067 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $0.04. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"shares","element":"transactionShares","label":"F24","text":"Represents an expected principal amount of $75,000 divided by $0.04."},{"field":"price","element":"transactionPricePerShare","label":"F22","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Manchester Explorer, L.P. two Common Stock Purchase Warrants, one with an exercise price of $0.04 per share and one with an exercise price of $0.067 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $0.04. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F22","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Manchester Explorer, L.P. two Common Stock Purchase Warrants, one with an exercise price of $0.04 per share and one with an exercise price of $0.067 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $0.04. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F22","text":"Pursuant to a letter agreement between the Issuer and the lenders of the July 2023 Notes, the Issuer shall issue Manchester Explorer, L.P. two Common Stock Purchase Warrants, one with an exercise price of $0.04 per share and one with an exercise price of $0.067 per share, substantially in the form of Exhibit 4.30 to the Form 10-K, each of which shall be exercisable for such number of shares of the Issuer's common stock calculated by dividing the principal amount of the lender's Future Advance Convertible Promissory Note by $0.04. The Common Stock Purchase Warrants shall be issued upon the Maturity Date unless otherwise issued in connection with the consummation of a Fundamental Transaction. Exhibit 4.30 of the Form 10-K is incorporated by reference to the extent applicable to the Common Stock Purchase Warrants and reference is also made to the Schedule 13D filed by the Reporting Persons on July 26, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities and warrants are owned directly by Manchester Explorer, L.P. (\"Explorer\") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (\"Manchester Management\"), the general partner of Explorer, (ii) Manchester Management PR, LLC (\"Manchester PR\"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1875000,"derivative":{"underlying":"Common Stock, par value $0.001","underlying_shares":1875000},"source":{"system":"sec-edgar","filing":"0000919574-23-004197","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1169253/000091957423004197/ownership.xml","form_type":"4"}}],"next_cursor":"2023-07-27T13:11:37.000000Z,1822304"}